Caricamento...
Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery
OBJECTIVES: The ongoing COVID-19 pandemic comprises a total of more than 2,350,000 cases and 160,000 deaths. The interest in anti-coronavirus drug development has been limited so far and effective methods to prevent or treat coronavirus infections in humans are still lacking. Urgent action is needed...
Salvato in:
| Pubblicato in: | Encephale |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
L'Encéphale, Paris.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188634/ https://ncbi.nlm.nih.gov/pubmed/32387014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.encep.2020.04.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|